MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ELVN has $490,875K in assets. $14,753K in debts. $101,732K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
3294.76%
Cash Ratio
694.42%
Debt to Asset Ratio
3.01%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other long-term assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
101,732 119,437
Marketable securities
375,833 371,066
Restricted cash
0 0
Prepaid expenses and other current assets
5,118 5,119
Total current assets
482,683 495,622
Property and equipment, gross
1,535 -
Less accumulated depreciation
1,136 -
Property and equipment, net
399 462
Operating lease right-of-use assets
475 564
Deferred offering costs
217 -
Other long-term assets
7,101 7,239
Total assets
490,875 503,887
Accounts payable
1,429 2,351
Accrued expenses and other current liabilities
13,221 12,860
Total current liabilities
14,650 15,211
Long-term liabilities
103 204
Total liabilities
14,753 15,415
Common stock, par value 0.001 authorized shares - 100,000,000 issued and outstanding shares - 59,261,286 and 48,936,459 at september 30, 2025 and december 31, 2024, respectively
59 59
Additional paid-in capital
793,341 785,941
Accumulated other comprehensive income
221 -177
Accumulated deficit
-317,499 -297,351
Total stockholders' equity
476,122 488,472
Total liabilities and stockholders' equity
490,875 503,887
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$1,535K Prepaid expenses andother current assets$5,118K Marketable securities$375,833K Cash and cashequivalents$101,732K Other long-termassets$7,101K Deferred offering costs$217K Operating leaseright-of-use assets$475K Property and equipment,net$399K Total current assets$482,683K Less accumulateddepreciation$1,136K Total assets$490,875K Total liabilities andstockholders' equity$490,875K Total stockholders'equity$476,122K Total liabilities$14,753K Accumulated deficit-$317,499K Accumulated othercomprehensive income$221K Additional paid-in capital$793,341K Long-term liabilities$103K Total currentliabilities$14,650K Common stock, par value0.001 authorized...$59K Accrued expenses andother current...$13,221K Accounts payable$1,429K

Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics, Inc. (ELVN)